Skip to Navigation

Panelist: Michael Kalos, PhD
Share This:

Michael Kalos, PhD

Episodes in which Michael Kalos, PhD appears

Adjunct Associate Professor
University of Pennsylvania Perelman School of Medicine
Director, Translational & Correlative Studies Lab
University of Pennsylavania

Dr. Kalos is a graduate of the University of Minnesota Medical school, where he received his degree from the department of Microbiology with an emphasis in Genetics.  He completed two postdoctoral fellowships at the Fred Hutchinson Cancer Research Center, where he studied mechanisms responsible for regulating gene expression, and in the laboratory of Philip Greenberg in the Program of Immunology where, among other accomplishments, he played a pioneering role in the development of genetic approaches to redirect lymphocyte specificity through transfer of T cell receptor chains.

Following his tenure at the Fred Hutchinson Cancer Research center, Dr. Kalos moved to Corixa Corporation, a biotechnology company in Seattle, where he played an instrumental role in the discovery and pre-clinical evaluation of novel cancer vaccines for prostate and lung cancer, work that led to a number of issued patents.

In 2004 Dr. Kalos was recruited to City of Hope as the founding director of a GLP-level laboratory that focused on the development and application of methodologies and approaches to evaluate in a comprehensive manner the impact and effectiveness of early stage immunotherapy protocols. 

In 2008 Dr. Kalos was recruited to the University of Pennsylvania School of Medicine where he is Adjunct Associate Professor in Pathology and Laboratory Medicine, and Founding Director of the Translational and Correlative Studies laboratory, where he is involved in the translational/clinical development and biomarker evaluation of novel cell based immunotherapeutics.

Dr. Kalos has given invited seminars on immunotherapy-related topics at national and international scientific meetings and institutions, has authored multiple primary and review articles as well as book chapters in the field of cancer immunotherapy, and is a member of the steering committees for national and international  immune biomarker working groups.

Have a comment?

If you'd like to send a comment to the producers of the show, please use our contact form, or feel free to post a comment on the wall of our Facebook Page.